pharma · Advanced solid tumors · Advanced Solid Tumors · TTRX
Turn Therapeutics
Turn Therapeutics (Nasdaq: is a pharma organization headquartered in Westlake Village, USA. It trades on NYSE under ticker TTRX. Primary therapeutic focus areas include Advanced solid tumors, Advanced Solid Tumors, Covid
Westlake Village, USA HQ
2015 Founded
11 Employees
Public company Type
TTRX · NYSE Ticker
Company details
- Status
- Public
- HQ
- Westlake Village, USA
- Founded
- 2015
- Employees
- 11
- Programs
- 6
- Drugs
- 3
- Patents
- 40
TPX-0005-07
Phase 2 · small molecule · Advanced solid tumors
TPX-0005-07 for Advanced solid tumors is a Phase 2 program (small_molecule) at Turn Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code TPX-0005-07
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Turn Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Advanced solid tumors
- Status
- active
- Trials
- 1